HEADER IMMUNOSUPPRESSANT 05-NOV-17 6BJ5 TITLE STRUCTURE OF THE CLINICALLY USED MYXOMAVIRAL SERINE PROTEASE INHIBITOR TITLE 2 1 (SERP-1) CAVEAT 6BJ5 NAG E 2 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE PROTEINASE INHIBITOR 1; COMPND 3 CHAIN: B, A, C; COMPND 4 FRAGMENT: UNP RESIDUES 1-315; COMPND 5 SYNONYM: SERPIN-1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SERINE PROTEINASE INHIBITOR 1; COMPND 9 CHAIN: F, G, H; COMPND 10 FRAGMENT: UNP RESIDUES 316-369; COMPND 11 SYNONYM: SERPIN-1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYXOMA VIRUS (STRAIN LAUSANNE); SOURCE 3 ORGANISM_COMMON: MYXV; SOURCE 4 ORGANISM_TAXID: 31530; SOURCE 5 STRAIN: LAUSANNE; SOURCE 6 GENE: SPI-1, SERP1, M008.1L; SOURCE 7 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MYXOMA VIRUS (STRAIN LAUSANNE); SOURCE 11 ORGANISM_COMMON: MYXV; SOURCE 12 ORGANISM_TAXID: 31530; SOURCE 13 STRAIN: LAUSANNE; SOURCE 14 GENE: SPI-1, SERP1, M008.1L; SOURCE 15 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS SERPIN, GLYCOSYLATION, PROTEASE INHIBITOR, IMMUNOSUPPRESSANT EXPDTA X-RAY DIFFRACTION AUTHOR B.P.MAHON,C.L.LOMELINO,R.MCKENNA REVDAT 6 23-OCT-24 6BJ5 1 REMARK REVDAT 5 04-OCT-23 6BJ5 1 HETSYN REVDAT 4 29-JUL-20 6BJ5 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 01-JAN-20 6BJ5 1 REMARK REVDAT 2 20-FEB-19 6BJ5 1 REMARK REVDAT 1 07-NOV-18 6BJ5 0 JRNL AUTH B.P.MAHON,C.L.LOMELINO,S.AMBADAPADI,J.YARON,S.KEINAN, JRNL AUTH 2 I.KURNIKOV,L.ZHANG,W.REEVES,M.A.PINARD,C.MACAULAY, JRNL AUTH 3 G.MCFADDEN,S.TIBBETTS,R.MCKENNA,A.LUCAS JRNL TITL STRUCTURE OF THE CLINICALLY USED MYXOMAVIRAL SERINE PROTEASE JRNL TITL 2 INHIBITOR 1 (SERP-1) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.8 REMARK 3 NUMBER OF REFLECTIONS : 46146 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.310 REMARK 3 FREE R VALUE TEST SET COUNT : 1990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8293 - 5.9748 0.99 3670 171 0.1749 0.1808 REMARK 3 2 5.9748 - 4.7640 0.99 3653 167 0.1580 0.1901 REMARK 3 3 4.7640 - 4.1682 0.99 3614 163 0.1492 0.2105 REMARK 3 4 4.1682 - 3.7900 0.99 3605 161 0.1779 0.2330 REMARK 3 5 3.7900 - 3.5199 0.75 2729 120 0.2354 0.2995 REMARK 3 6 3.5199 - 3.3134 0.99 3574 163 0.2293 0.3023 REMARK 3 7 3.3134 - 3.1482 0.99 3569 155 0.2450 0.2977 REMARK 3 8 3.1482 - 3.0116 0.99 3610 158 0.2517 0.3312 REMARK 3 9 3.0116 - 2.8960 0.99 3563 175 0.2609 0.3376 REMARK 3 10 2.8960 - 2.7964 0.95 3429 154 0.2747 0.3361 REMARK 3 11 2.7964 - 2.7092 0.80 2853 136 0.2731 0.2922 REMARK 3 12 2.7092 - 2.6319 0.69 2532 98 0.2639 0.3487 REMARK 3 13 2.6319 - 2.5628 0.58 2119 97 0.2531 0.3260 REMARK 3 14 2.5628 - 2.5004 0.45 1636 72 0.2632 0.3548 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.850 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.86 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 8113 REMARK 3 ANGLE : 1.354 10993 REMARK 3 CHIRALITY : 0.080 1305 REMARK 3 PLANARITY : 0.008 1381 REMARK 3 DIHEDRAL : 16.482 4888 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -28.7253 34.2466 29.6432 REMARK 3 T TENSOR REMARK 3 T11: 0.0569 T22: 0.0461 REMARK 3 T33: 0.0522 T12: 0.0105 REMARK 3 T13: -0.0032 T23: -0.0056 REMARK 3 L TENSOR REMARK 3 L11: 0.0822 L22: 0.0784 REMARK 3 L33: 0.1216 L12: -0.0154 REMARK 3 L13: 0.0809 L23: -0.0164 REMARK 3 S TENSOR REMARK 3 S11: -0.0395 S12: 0.0151 S13: -0.0038 REMARK 3 S21: 0.0410 S22: 0.0103 S23: -0.0187 REMARK 3 S31: -0.0550 S32: 0.0142 S33: -0.0754 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BJ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000230952. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : F1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51618 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.60200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER, PHENIX REMARK 200 STARTING MODEL: 3LW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM CHLORIDE, 0.05 M REMARK 280 MAGNESIUM CHLORIDE HEXAHYDRATE, 0.05 M TRIS-HCL PH 7.5, 10% W/V REMARK 280 POLYETHYLENE GLYCOL (PEG) 4,000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.50600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.03300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.50600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 61.03300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, H, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 TYR B 3 REMARK 465 LEU B 4 REMARK 465 VAL B 5 REMARK 465 LEU B 6 REMARK 465 VAL B 7 REMARK 465 LEU B 8 REMARK 465 CYS B 9 REMARK 465 LEU B 10 REMARK 465 THR B 11 REMARK 465 SER B 12 REMARK 465 CYS B 13 REMARK 465 ALA B 14 REMARK 465 CYS B 15 REMARK 465 ARG B 16 REMARK 465 THR B 123A REMARK 465 GLY B 123B REMARK 465 GLY B 123C REMARK 465 ASP B 123D REMARK 465 ARG B 189A REMARK 465 ASN B 189B REMARK 465 LEU F 316 REMARK 465 ILE F 317 REMARK 465 PRO F 318 REMARK 465 ARG F 319 REMARK 465 ASN F 320 REMARK 465 ALA F 321 REMARK 465 GLU F 360 REMARK 465 GLY F 361 REMARK 465 ARG F 362 REMARK 465 ASP F 363 REMARK 465 ASP F 364 REMARK 465 VAL F 365 REMARK 465 VAL F 366 REMARK 465 SER F 367 REMARK 465 SER F 368 REMARK 465 VAL F 369 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 TYR A 3 REMARK 465 LEU A 4 REMARK 465 VAL A 5 REMARK 465 LEU A 6 REMARK 465 VAL A 7 REMARK 465 LEU A 8 REMARK 465 CYS A 9 REMARK 465 LEU A 10 REMARK 465 THR A 11 REMARK 465 SER A 12 REMARK 465 CYS A 13 REMARK 465 ALA A 14 REMARK 465 CYS A 15 REMARK 465 LYS A 122A REMARK 465 THR A 122B REMARK 465 GLY A 122C REMARK 465 GLY A 122D REMARK 465 ASP A 122E REMARK 465 ARG A 124A REMARK 465 VAL A 124B REMARK 465 ASN A 187A REMARK 465 LEU G 316 REMARK 465 ILE G 317 REMARK 465 PRO G 318 REMARK 465 ARG G 319 REMARK 465 ASN G 320 REMARK 465 GLU G 360 REMARK 465 GLY G 361 REMARK 465 ARG G 362 REMARK 465 ASP G 363 REMARK 465 ASP G 364 REMARK 465 VAL G 365 REMARK 465 VAL G 366 REMARK 465 SER G 367 REMARK 465 SER G 368 REMARK 465 VAL G 369 REMARK 465 MET C 1 REMARK 465 LYS C 2 REMARK 465 TYR C 3 REMARK 465 LEU C 4 REMARK 465 VAL C 5 REMARK 465 LEU C 6 REMARK 465 VAL C 7 REMARK 465 LEU C 8 REMARK 465 CYS C 9 REMARK 465 LEU C 10 REMARK 465 THR C 11 REMARK 465 SER C 12 REMARK 465 CYS C 13 REMARK 465 ALA C 14 REMARK 465 CYS C 15 REMARK 465 ARG C 16 REMARK 465 ASN C 107A REMARK 465 THR C 122A REMARK 465 GLY C 122B REMARK 465 GLY C 122C REMARK 465 ASP C 122D REMARK 465 VAL C 122E REMARK 465 PRO C 122F REMARK 465 ARG C 122G REMARK 465 VAL C 122H REMARK 465 LEU C 122I REMARK 465 ASP C 122J REMARK 465 LEU H 316 REMARK 465 ILE H 317 REMARK 465 PRO H 318 REMARK 465 ARG H 319 REMARK 465 ASN H 320 REMARK 465 GLY H 361 REMARK 465 ARG H 362 REMARK 465 ASP H 363 REMARK 465 ASP H 364 REMARK 465 VAL H 365 REMARK 465 VAL H 366 REMARK 465 SER H 367 REMARK 465 SER H 368 REMARK 465 VAL H 369 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 16 CB CG CD NE CZ NH1 NH2 REMARK 470 ASP G 358 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN B 28 O5 NAG D 1 1.62 REMARK 500 ND2 ASN C 28 C1 NAG E 1 2.00 REMARK 500 OG SER C 272 OG SER C 274 2.07 REMARK 500 NH2 ARG B 24 O LEU B 221 2.09 REMARK 500 O THR A 91 OG SER A 95 2.10 REMARK 500 OD2 ASP A 81 OG SER A 83 2.11 REMARK 500 OD2 ASP C 81 OG SER C 83 2.15 REMARK 500 O ALA A 51 NZ LYS A 56 2.15 REMARK 500 O LYS A 113 ND2 ASN A 117 2.17 REMARK 500 OD1 ASP C 259 NH2 ARG C 265 2.18 REMARK 500 O GLU A 63 NH2 ARG A 97 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 131 CG - CD - NE ANGL. DEV. = 16.9 DEGREES REMARK 500 LEU G 322 CA - CB - CG ANGL. DEV. = 14.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER B 109 175.31 -56.62 REMARK 500 PRO B 125 75.12 -102.60 REMARK 500 VAL B 127 46.10 -71.96 REMARK 500 ASP B 236 152.38 176.42 REMARK 500 ILE A 18 -54.69 68.23 REMARK 500 ASP A 132 -2.76 69.86 REMARK 500 ARG A 200 2.80 59.71 REMARK 500 ASP C 113 -63.56 -96.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG D 1 REMARK 610 NAG E 1 DBREF 6BJ5 B 1 309 UNP P12393 SPI1_MYXVL 1 315 DBREF 6BJ5 F 316 369 UNP P12393 SPI1_MYXVL 316 369 DBREF 6BJ5 A 1 307 UNP P12393 SPI1_MYXVL 1 315 DBREF 6BJ5 G 316 369 UNP P12393 SPI1_MYXVL 316 369 DBREF 6BJ5 C 1 304 UNP P12393 SPI1_MYXVL 1 315 DBREF 6BJ5 H 316 369 UNP P12393 SPI1_MYXVL 316 369 SEQRES 1 B 315 MET LYS TYR LEU VAL LEU VAL LEU CYS LEU THR SER CYS SEQRES 2 B 315 ALA CYS ARG ASP ILE GLY LEU TRP THR PHE ARG TYR VAL SEQRES 3 B 315 TYR ASN GLU SER ASP ASN VAL VAL PHE SER PRO TYR GLY SEQRES 4 B 315 LEU THR SER ALA LEU SER VAL LEU ARG ILE ALA ALA GLY SEQRES 5 B 315 GLY ASN THR LYS ARG GLU ILE ASP VAL PRO GLU SER VAL SEQRES 6 B 315 VAL GLU ASP SER ASP ALA PHE LEU ALA LEU ARG GLU LEU SEQRES 7 B 315 PHE VAL ASP ALA SER VAL PRO LEU ARG PRO GLU PHE THR SEQRES 8 B 315 ALA GLU PHE SER SER ARG PHE ASN THR SER VAL GLN ARG SEQRES 9 B 315 VAL THR PHE ASN SER GLU ASN VAL LYS ASP VAL ILE ASN SEQRES 10 B 315 SER TYR VAL LYS ASP LYS THR GLY GLY ASP VAL PRO ARG SEQRES 11 B 315 VAL LEU ASP ALA SER LEU ASP ARG ASP THR LYS MET LEU SEQRES 12 B 315 LEU LEU SER SER VAL ARG MET LYS THR SER TRP ARG HIS SEQRES 13 B 315 VAL PHE ASP PRO SER PHE THR THR ASP GLN PRO PHE TYR SEQRES 14 B 315 SER GLY ASN VAL THR TYR LYS VAL ARG MET MET ASN LYS SEQRES 15 B 315 ILE ASP THR LEU LYS THR GLU THR PHE THR LEU ARG ASN SEQRES 16 B 315 VAL GLY TYR SER VAL THR GLU LEU PRO TYR LYS ARG ARG SEQRES 17 B 315 GLN THR ALA MET LEU LEU VAL VAL PRO ASP ASP LEU GLY SEQRES 18 B 315 GLU ILE VAL ARG ALA LEU ASP LEU SER LEU VAL ARG PHE SEQRES 19 B 315 TRP ILE ARG ASN MET ARG LYS ASP VAL CYS GLN VAL VAL SEQRES 20 B 315 MET PRO LYS PHE SER VAL GLU SER VAL LEU ASP LEU ARG SEQRES 21 B 315 ASP ALA LEU GLN ARG LEU GLY VAL ARG ASP ALA PHE ASP SEQRES 22 B 315 PRO SER ARG ALA ASP PHE GLY GLN ALA SER PRO SER ASN SEQRES 23 B 315 ASP LEU TYR VAL THR LYS VAL LEU GLN THR SER LYS ILE SEQRES 24 B 315 GLU ALA ASP GLU ARG GLY THR THR ALA SER SER ASP THR SEQRES 25 B 315 ALA ILE THR SEQRES 1 F 54 LEU ILE PRO ARG ASN ALA LEU THR ALA ILE VAL ALA ASN SEQRES 2 F 54 LYS PRO PHE MET PHE LEU ILE TYR HIS LYS PRO THR THR SEQRES 3 F 54 THR VAL LEU PHE MET GLY THR ILE THR LYS GLY GLU LYS SEQRES 4 F 54 VAL ILE TYR ASP THR GLU GLY ARG ASP ASP VAL VAL SER SEQRES 5 F 54 SER VAL SEQRES 1 A 315 MET LYS TYR LEU VAL LEU VAL LEU CYS LEU THR SER CYS SEQRES 2 A 315 ALA CYS ARG ASP ILE GLY LEU TRP THR PHE ARG TYR VAL SEQRES 3 A 315 TYR ASN GLU SER ASP ASN VAL VAL PHE SER PRO TYR GLY SEQRES 4 A 315 LEU THR SER ALA LEU SER VAL LEU ARG ILE ALA ALA GLY SEQRES 5 A 315 GLY ASN THR LYS ARG GLU ILE ASP VAL PRO GLU SER VAL SEQRES 6 A 315 VAL GLU ASP SER ASP ALA PHE LEU ALA LEU ARG GLU LEU SEQRES 7 A 315 PHE VAL ASP ALA SER VAL PRO LEU ARG PRO GLU PHE THR SEQRES 8 A 315 ALA GLU PHE SER SER ARG PHE ASN THR SER VAL GLN ARG SEQRES 9 A 315 VAL THR PHE ASN SER GLU ASN VAL LYS ASP VAL ILE ASN SEQRES 10 A 315 SER TYR VAL LYS ASP LYS THR GLY GLY ASP VAL PRO ARG SEQRES 11 A 315 VAL LEU ASP ALA SER LEU ASP ARG ASP THR LYS MET LEU SEQRES 12 A 315 LEU LEU SER SER VAL ARG MET LYS THR SER TRP ARG HIS SEQRES 13 A 315 VAL PHE ASP PRO SER PHE THR THR ASP GLN PRO PHE TYR SEQRES 14 A 315 SER GLY ASN VAL THR TYR LYS VAL ARG MET MET ASN LYS SEQRES 15 A 315 ILE ASP THR LEU LYS THR GLU THR PHE THR LEU ARG ASN SEQRES 16 A 315 VAL GLY TYR SER VAL THR GLU LEU PRO TYR LYS ARG ARG SEQRES 17 A 315 GLN THR ALA MET LEU LEU VAL VAL PRO ASP ASP LEU GLY SEQRES 18 A 315 GLU ILE VAL ARG ALA LEU ASP LEU SER LEU VAL ARG PHE SEQRES 19 A 315 TRP ILE ARG ASN MET ARG LYS ASP VAL CYS GLN VAL VAL SEQRES 20 A 315 MET PRO LYS PHE SER VAL GLU SER VAL LEU ASP LEU ARG SEQRES 21 A 315 ASP ALA LEU GLN ARG LEU GLY VAL ARG ASP ALA PHE ASP SEQRES 22 A 315 PRO SER ARG ALA ASP PHE GLY GLN ALA SER PRO SER ASN SEQRES 23 A 315 ASP LEU TYR VAL THR LYS VAL LEU GLN THR SER LYS ILE SEQRES 24 A 315 GLU ALA ASP GLU ARG GLY THR THR ALA SER SER ASP THR SEQRES 25 A 315 ALA ILE THR SEQRES 1 G 54 LEU ILE PRO ARG ASN ALA LEU THR ALA ILE VAL ALA ASN SEQRES 2 G 54 LYS PRO PHE MET PHE LEU ILE TYR HIS LYS PRO THR THR SEQRES 3 G 54 THR VAL LEU PHE MET GLY THR ILE THR LYS GLY GLU LYS SEQRES 4 G 54 VAL ILE TYR ASP THR GLU GLY ARG ASP ASP VAL VAL SER SEQRES 5 G 54 SER VAL SEQRES 1 C 315 MET LYS TYR LEU VAL LEU VAL LEU CYS LEU THR SER CYS SEQRES 2 C 315 ALA CYS ARG ASP ILE GLY LEU TRP THR PHE ARG TYR VAL SEQRES 3 C 315 TYR ASN GLU SER ASP ASN VAL VAL PHE SER PRO TYR GLY SEQRES 4 C 315 LEU THR SER ALA LEU SER VAL LEU ARG ILE ALA ALA GLY SEQRES 5 C 315 GLY ASN THR LYS ARG GLU ILE ASP VAL PRO GLU SER VAL SEQRES 6 C 315 VAL GLU ASP SER ASP ALA PHE LEU ALA LEU ARG GLU LEU SEQRES 7 C 315 PHE VAL ASP ALA SER VAL PRO LEU ARG PRO GLU PHE THR SEQRES 8 C 315 ALA GLU PHE SER SER ARG PHE ASN THR SER VAL GLN ARG SEQRES 9 C 315 VAL THR PHE ASN SER GLU ASN VAL LYS ASP VAL ILE ASN SEQRES 10 C 315 SER TYR VAL LYS ASP LYS THR GLY GLY ASP VAL PRO ARG SEQRES 11 C 315 VAL LEU ASP ALA SER LEU ASP ARG ASP THR LYS MET LEU SEQRES 12 C 315 LEU LEU SER SER VAL ARG MET LYS THR SER TRP ARG HIS SEQRES 13 C 315 VAL PHE ASP PRO SER PHE THR THR ASP GLN PRO PHE TYR SEQRES 14 C 315 SER GLY ASN VAL THR TYR LYS VAL ARG MET MET ASN LYS SEQRES 15 C 315 ILE ASP THR LEU LYS THR GLU THR PHE THR LEU ARG ASN SEQRES 16 C 315 VAL GLY TYR SER VAL THR GLU LEU PRO TYR LYS ARG ARG SEQRES 17 C 315 GLN THR ALA MET LEU LEU VAL VAL PRO ASP ASP LEU GLY SEQRES 18 C 315 GLU ILE VAL ARG ALA LEU ASP LEU SER LEU VAL ARG PHE SEQRES 19 C 315 TRP ILE ARG ASN MET ARG LYS ASP VAL CYS GLN VAL VAL SEQRES 20 C 315 MET PRO LYS PHE SER VAL GLU SER VAL LEU ASP LEU ARG SEQRES 21 C 315 ASP ALA LEU GLN ARG LEU GLY VAL ARG ASP ALA PHE ASP SEQRES 22 C 315 PRO SER ARG ALA ASP PHE GLY GLN ALA SER PRO SER ASN SEQRES 23 C 315 ASP LEU TYR VAL THR LYS VAL LEU GLN THR SER LYS ILE SEQRES 24 C 315 GLU ALA ASP GLU ARG GLY THR THR ALA SER SER ASP THR SEQRES 25 C 315 ALA ILE THR SEQRES 1 H 54 LEU ILE PRO ARG ASN ALA LEU THR ALA ILE VAL ALA ASN SEQRES 2 H 54 LYS PRO PHE MET PHE LEU ILE TYR HIS LYS PRO THR THR SEQRES 3 H 54 THR VAL LEU PHE MET GLY THR ILE THR LYS GLY GLU LYS SEQRES 4 H 54 VAL ILE TYR ASP THR GLU GLY ARG ASP ASP VAL VAL SER SEQRES 5 H 54 SER VAL HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET NAG A 401 14 HET P15 C 401 20 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM P15 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 7 NAG 5(C8 H15 N O6) FORMUL 10 P15 C13 H28 O7 FORMUL 11 HOH *58(H2 O) HELIX 1 AA1 ASP B 17 THR B 22 1 6 HELIX 2 AA2 THR B 22 TYR B 27 1 6 HELIX 3 AA3 SER B 36 ALA B 50 1 15 HELIX 4 AA4 GLY B 52 ILE B 59 1 8 HELIX 5 AA5 ARG B 87 ASN B 99 1 13 HELIX 6 AA6 ASN B 111 LYS B 121 1 11 HELIX 7 AA7 ASP B 155 THR B 159 5 5 HELIX 8 AA8 ASP B 213 LEU B 221 1 9 HELIX 9 AA9 ASP B 222 MET B 233 1 12 HELIX 10 AB1 LEU B 253 LEU B 260 1 8 HELIX 11 AB2 ARG B 263 ASP B 267 5 5 HELIX 12 AB3 ILE A 18 TYR A 27 1 10 HELIX 13 AB4 SER A 36 ALA A 51 1 16 HELIX 14 AB5 GLY A 52 ILE A 59 1 8 HELIX 15 AB6 ARG A 87 ASN A 99 1 13 HELIX 16 AB7 ASN A 111 VAL A 120 1 10 HELIX 17 AB8 ASP A 152 THR A 156 5 5 HELIX 18 AB9 ASP A 211 LEU A 219 1 9 HELIX 19 AC1 ASP A 220 MET A 231 1 12 HELIX 20 AC2 LEU A 251 LEU A 258 1 8 HELIX 21 AC3 ARG A 261 ASP A 265 5 5 HELIX 22 AC4 ILE C 18 THR C 22 1 5 HELIX 23 AC5 THR C 22 TYR C 27 1 6 HELIX 24 AC6 SER C 36 ALA C 51 1 16 HELIX 25 AC7 GLY C 52 ILE C 59 1 8 HELIX 26 AC8 ARG C 87 ASN C 99 1 13 HELIX 27 AC9 ASN C 110 ASP C 121 1 12 HELIX 28 AD1 ASP C 148 THR C 152 5 5 HELIX 29 AD2 ASP C 208 LEU C 216 1 9 HELIX 30 AD3 ASP C 217 MET C 228 1 12 HELIX 31 AD4 LEU C 248 LEU C 255 1 8 HELIX 32 AD5 ARG C 258 ASP C 262 5 5 SHEET 1 AA1 6 VAL B 33 PHE B 35 0 SHEET 2 AA1 6 THR F 342 ILE F 349 -1 O MET F 346 N PHE B 35 SHEET 3 AA1 6 PHE F 331 HIS F 337 -1 N ILE F 335 O PHE F 345 SHEET 4 AA1 6 THR B 204 PRO B 211 -1 N VAL B 209 O MET F 332 SHEET 5 AA1 6 TYR B 192 PRO B 198 -1 N LEU B 197 O MET B 206 SHEET 6 AA1 6 THR B 184 PHE B 187 -1 N PHE B 187 O TYR B 192 SHEET 1 AA2 6 GLN B 103 VAL B 105 0 SHEET 2 AA2 6 LEU B 73 ASP B 81 1 N LEU B 78 O GLN B 103 SHEET 3 AA2 6 MET B 138 SER B 149 -1 O LEU B 139 N PHE B 79 SHEET 4 AA2 6 GLY B 299 ILE B 308 -1 O SER B 304 N VAL B 144 SHEET 5 AA2 6 VAL B 287 ASP B 296 -1 N LEU B 288 O ALA B 307 SHEET 6 AA2 6 PHE B 245 ASP B 252 -1 N LEU B 251 O GLN B 289 SHEET 1 AA3 4 THR B 160 SER B 166 0 SHEET 2 AA3 4 VAL B 169 THR B 181 -1 O VAL B 173 N GLN B 162 SHEET 3 AA3 4 VAL B 237 PRO B 243 -1 O CYS B 238 N ASP B 180 SHEET 4 AA3 4 THR F 323 VAL F 326 1 O ILE F 325 N GLN B 239 SHEET 1 AA4 3 THR B 160 SER B 166 0 SHEET 2 AA4 3 VAL B 169 THR B 181 -1 O VAL B 173 N GLN B 162 SHEET 3 AA4 3 LYS F 354 ILE F 356 -1 O ILE F 356 N THR B 170 SHEET 1 AA5 8 VAL A 33 PHE A 35 0 SHEET 2 AA5 8 THR G 342 ILE G 349 -1 O MET G 346 N PHE A 35 SHEET 3 AA5 8 PHE G 331 HIS G 337 -1 N ILE G 335 O PHE G 345 SHEET 4 AA5 8 THR A 202 PRO A 209 -1 N LEU A 205 O LEU G 334 SHEET 5 AA5 8 GLY A 189 PRO A 196 -1 N THR A 193 O LEU A 206 SHEET 6 AA5 8 VAL A 166 THR A 185 -1 N PHE A 184 O TYR A 190 SHEET 7 AA5 8 ARG A 232 PRO A 241 -1 O CYS A 236 N ASP A 177 SHEET 8 AA5 8 THR G 323 VAL G 326 1 O ILE G 325 N GLN A 237 SHEET 1 AA6 3 THR A 157 SER A 163 0 SHEET 2 AA6 3 VAL A 166 THR A 185 -1 O MET A 172 N THR A 157 SHEET 3 AA6 3 LYS G 354 VAL G 355 -1 O LYS G 354 N LYS A 169 SHEET 1 AA7 6 GLN A 103 VAL A 105 0 SHEET 2 AA7 6 LEU A 73 ASP A 81 1 N LEU A 78 O GLN A 103 SHEET 3 AA7 6 MET A 135 SER A 146 -1 O LEU A 138 N GLU A 77 SHEET 4 AA7 6 GLY A 297 ILE A 306 -1 O THR A 304 N SER A 139 SHEET 5 AA7 6 VAL A 285 ASP A 294 -1 N LEU A 286 O ALA A 305 SHEET 6 AA7 6 PHE A 243 ASP A 250 -1 N LEU A 249 O GLN A 287 SHEET 1 AA8 6 VAL C 33 PHE C 35 0 SHEET 2 AA8 6 THR H 342 ILE H 349 -1 O MET H 346 N PHE C 35 SHEET 3 AA8 6 PHE H 331 HIS H 337 -1 N ILE H 335 O PHE H 345 SHEET 4 AA8 6 THR C 199 PRO C 206 -1 N VAL C 204 O MET H 332 SHEET 5 AA8 6 TYR C 187 PRO C 193 -1 N LEU C 192 O MET C 201 SHEET 6 AA8 6 THR C 177 PHE C 180 -1 N PHE C 180 O TYR C 187 SHEET 1 AA9 6 GLN C 103 VAL C 105 0 SHEET 2 AA9 6 LEU C 73 ASP C 81 1 N LEU C 78 O GLN C 103 SHEET 3 AA9 6 MET C 131 SER C 142 -1 O LEU C 132 N PHE C 79 SHEET 4 AA9 6 GLY C 294 ILE C 303 -1 O ILE C 303 N LEU C 133 SHEET 5 AA9 6 VAL C 282 ALA C 290 -1 N LEU C 283 O ALA C 302 SHEET 6 AA9 6 PHE C 240 ASP C 247 -1 N LEU C 246 O GLN C 284 SHEET 1 AB1 4 THR C 153 SER C 159 0 SHEET 2 AB1 4 VAL C 162 THR C 174 -1 O VAL C 166 N GLN C 155 SHEET 3 AB1 4 VAL C 232 PRO C 238 -1 O CYS C 233 N ASP C 173 SHEET 4 AB1 4 THR H 323 VAL H 326 1 O ILE H 325 N VAL C 236 SHEET 1 AB2 3 THR C 153 SER C 159 0 SHEET 2 AB2 3 VAL C 162 THR C 174 -1 O VAL C 166 N GLN C 155 SHEET 3 AB2 3 LYS H 354 VAL H 355 -1 O LYS H 354 N LYS C 165 LINK ND2 ASN A 28 C1 NAG A 401 1555 1555 1.47 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.42 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 CISPEP 1 LYS B 121 ASP B 122 0 2.41 CISPEP 2 LYS A 198 ARG A 199 0 0.61 CRYST1 99.012 122.066 130.095 90.00 94.88 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010100 0.000000 0.000861 0.00000 SCALE2 0.000000 0.008192 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007715 0.00000